A summary of the collection
Set is a provider of integrated injection solutions in inland areas, mainly designing and manufacturing moulds, as well as injection components design and manufacturing services. The collection company also charges the business to build electrical equipment products in the way of OEM. The main design and production collection uses the internal injection molding process to produce injection moulds for injection components. The collection can design and customize the injection mold and its cavity according to the design, characteristics and size of the injection parts. The integrated moulds are up to the highest precision MT1 precision level as defined in the national standard "GB/T14486-2008-dimensional tolerances for plastic molded parts".
The collection uses injection moulds produced by the injection molding process and collection, or some contractors to manufacture injection molding components for public furniture, household electronics and automobiles, etc.
Industry summary
According to the Frost Sullivan report, China's injection moulds are the size of the market. in terms of income, it has risen from 52.9 billion yuan in 2011 to 80.8 billion yuan in 2016, with a complex annual growth rate of 8.8%. It is expected to rise at a compound annual growth rate of 11.1% between 2017 and 2021. The market size of injection molding components made of injection moulds rose from 1092 billion yuan in 2011 to 1760 billion yuan in 2016, with a compound annual growth rate of 10.0 percent. It is expected that from 2017 to 2021, the combined annual growth rate will be 8.8 percent. In terms of revenue, the domestic manufacturing market model has increased from 7 billion yuan in 2011 to 1.8 billion yuan in 2016, with a combined annual growth rate of 21.9 percent.
Cymbals
The production of electricity products accounts for most of the revenue, and the power products of the collection are mainly produced under the brand name "blu" as Fontem. However, there is no agreement with the Fontem and no commitment is obtained from the Fontem. In addition, the existing agreement between the Consortium and Fontem will be signed in March 2020, after which the Agreement may not be renewed with Fontem on reasonable commercial terms.
Valuation
According to the IPO document, as of the end of August 2017, based on the 1.55 shares expected to be issued after the completion of the sale of long-term shares, shares should account for HK $0.56 to HK $0.58 per share of tangible assets (excluding HK $14.71 million related to listing in the first eight months up to 2017).
The purpose of the income is:
Based on the sale cost of HK $0.70 (the median of the range of sales), after deducting the estimated expenditure payable on the issue of shares, the net income is estimated at HK $78.3 million.